49
Jeanne Shaheen
Serving in office
Scheduled research active
Main board
The signal is improving, but the lifetime record is still thin.
This profile keeps a lifetime office and promise record. The trust score is designed to stay close to 50 until enough claims and evidence are reviewed.
Breakdown
- Delivered during the term promised: 8 x 1.0
- Delivered in a later elected term: 0 x 0.8
- Partial delivery: 3 x 0.4
- Never delivered: 8 x 0.0
- Disputed claims tracked separately: 0
- Reviewed promises in current record: 19
- Confidence: 61%
- Current claim count: 26
- Current evidence count: 117
Office History
-
U.S. Senator
New Hampshire · current
Current federal elected office. Shaheen was sworn in on January 3, 2009. -
U.S. Senator
New Hampshire · current
Historical elected offices still need research. -
U.S. Senator candidate
New Hampshire
Federal reelection campaign for U.S. Senate; successful. -
U.S. Senator candidate
New Hampshire
Federal reelection campaign for U.S. Senate; successful. -
U.S. Senate candidate
New Hampshire
Federal campaign for U.S. Senate; successful rematch against John E. Sununu. -
U.S. Senate candidate
New Hampshire
Federal campaign for U.S. Senate; unsuccessful challenge to the open Class II seat.
- Will not support an extension of sanctions relief for Russian oil exports.
- Will engage in an intensive diplomatic effort, alongside allies, to conclude the conflict with Iran and ensure Iran does not develop a nuclear weapon.
- Will advocate for an automatic and swift tariff tax refund process to provide relief for small businesses and families.
- Will advocate for the reimposition of U.S. sanctions on Milorad Dodik.
- Will cap monthly out-of-pocket insulin costs at $35.
- Will lead a bipartisan congressional delegation to the Arctic to examine U.S. and allied Arctic security, infrastructure, and research capabilities.
- Will require DHS to consult communities before new ICE detention or processing facilities are opened.
- Will raise salaries for Bureau of Prisons law enforcement officers.
- Will co-lead legislation to expand U.S. sanctions on Russia's shadow fleet and energy sector.
- Will establish a State Department-led U.S. Technology Procurement Program to streamline the procurement of U.S. cyber and digital technologies by foreign allies and partners.
- Will authorize $500 million over FY26-31 for the CDT fund to support implementation of the U.S. Technology Procurement Program.
- Will pursue comprehensive healthcare reform that lowers costs and improves access for working families and businesses.
- Will support comprehensive immigration reform that strengthens the border, verifies employment, and preserves visas for high-skilled workers.
- Will continue working to ensure small businesses have the tools they need to succeed.
- Will continue to lead bipartisan efforts to stop predatory surprise medical bills.
- Will expand technical and vocational training and apprenticeship programs and increase grant funding for community colleges.
- Will create a pilot grant program for states to identify uninsured diabetes patients and provide them insulin at $35 a month.
- Will require pharmacy benefit managers to pass through all insulin rebates and manufacturer discounts to plan sponsors.
- Will establish an insulin resource center and hotline for uninsured diabetes patients.
- Will push legislation to make child care more affordable and accessible for working families by strengthening the child care workforce.
- Will authorize over $65 billion over 10 years in federal funding for substance use treatment and prevention through the Turn the Tide Act.
- Will increase State Opioid Response treatment grant funding to $5.5 billion per year for five years and allow use for non-opioid substance use disorders.
- Will expand HUD's Recovery Housing Program and provide states more consistent funding to support patients in recovery.
- Will establish a grant program modeled on Manchester's Adverse Childhood Experiences Response Team program for children exposed to trauma related to substance use disorders.
- Will require private insurers and Medicare Part D plans to cover Naloxone without co-pays or deductibles.
- Will prohibit insurers from imposing administrative barriers such as prior authorization that delay the start of medication-assisted treatment.
Method note
Long term, this app should score against a manually reviewed promise ledger that spans every elected office the candidate has held. The current model uses a Bayesian-style shrinkage step: thin records are pulled back toward 50 so the UI does not overstate certainty.
Claim occurrences, evidence, and future AI adjudications are all designed to store provider and model provenance. Formula version: 0.1.0.